May 09, 2023 / 03:00PM GMT
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst
Thank you for joining us. Thanks for being here.
My name is Mike Ryskin. I'm on the BofA Life Science Tools & Diagnostics team with the other senior analyst, Derik De Bruin. And it's my great pleasure to welcome you all here at wonderful, beautiful Las Vegas for the 2023 version of the BofA Global Healthcare Conference. Really appreciate your attendance in this event. For our first session to kick off the conference, we are joined by Michael Stubblefield, CEO of Avantor. Michael, thanks so much for taking the time and coming out to talk with us.
Michael Stubblefield - Avantor, Inc. - President, CEO & Director
We're happy to be here. Thanks for including us.
Questions and Answers:
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research AnalystSo just to kick it off, I mean, you reported 1Q results recently. Maybe you can give